SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Albany Molecular Research, Inc. (AMRI)

NEW YORK, Aug. 9, 2016 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Albany Molecular Research, Inc. ("Amri" or the "Company") (NASDAQ: AMRI). Such investors are advised to contact Peretz Bronstein or his investor relations analyst, Yael Hurwitz at [e-mail] or 212-697-6484.

The investigation concerns whether Amri and certain of its officers and/or directors have violated Sections 10(b) of the Securities Exchange Act of 1934 and have breached their fiduciary duties to the Company and its shareholders by failing to implement adequate internal controls over its management and disclosure procedures.

Amri is a contract research and manufacturing organization that provides drug discovery, development, cGMP manufacturing and aseptic fill and finish to the pharmaceutical and biotechnology industries.

Amri has allegedly been hiding from its investors information about a weather-related power outage at its New Mexico laboratory in July 2014 that spoiled its inventory. Particularly, Amri's Chief Executive Officer apparently knew about the power outage and this laboratory's importance to core operations and nevertheless failed to inform shareholders. Truth of this power outage was not released until November 5, 2014, when Amri announced the need to temporarily close the facility and dispose of the reuined inventory. Following this news, Amri stock dropped $6.08 per share, or 35%, to close at $16.59 per share on November 5, 2014.

If you purchased Amri shares or if you are aware of any facts relating to this investigation, you can assist this investigation by visiting the firm's site: http://www.bgandg.com/amri. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484 or via email [e-mail]. Those who inquire by e-mail are encouraged to include their mailing address, email and telephone number.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | [e-mail]

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert-bronstein-gewirtz--grossman-llc-announces-investigation-of-albany-molecular-research-inc-amri-300310753.html

SOURCE Bronstein, Gewirtz & Grossman, LLC

Copyright 2016 PR Newswire